Earnings

Orion Engineered Carbons Confronts Cycle Lows With Cost Reset and Disciplined 2026 Outlook

Orion Engineered Carbons Confronts Cycle Lows With Cost Reset and Disciplined 2026 Outlook

Orion Engineered Carbons S.A. (NYSE: OEC) is a Luxembourg-based global supplier of specialty and rubber carbon black serving tire, coatings,…

MITT Solidifies Market Position with Arc Home Expansion and Disciplined Securitization

TPG Mortgage Investment Trust, Inc. (NYSE: MITT), with a market capitalization of approximately $0.29 billion, is a residential mortgage real estate…

Energy Transfer LP Announces Record Full-Year 2025 Results and Increased 2026 Guidance

Energy Transfer LP (NYSE: ET) today reported financial and operational results for the fourth quarter and fiscal year ended December…

DFIN’s Software Pivot Pays Off: High Margins and Recurring Revenue Lead the Way

Donnelley Financial Solutions Inc (NYSE: DFIN), a provider of regulatory compliance, financial technology, and risk management solutions, had a market…

Cardiovascular and Robotics Drive Medtronic’s Record 10-Quarter Revenue Spike

Medtronic PLC (NYSE: MDT) is a Dublin-based global medical technology company with a market capitalization of approximately $110 billion. The…

CNH Industrial Beats Q4 Estimates but Braces for 2026 Industry Trough

CNH Industrial NV (NYSE: CNH) reported fourth-quarter 2025 financial results on Tuesday that exceeded Wall Street expectations, driven by strong…

Tower Semiconductor Q4 2025 Drives Record Revenue and Aggressive CapEx Expansion

Tower Semiconductor (NASDAQ: TSEM, TASE: TSEM) delivered a standout performance for the fourth quarter ended December 31, 2025, reporting record…

NeoGenomics Full Year 2025 Revenue Rises to $727 Million

NeoGenomics, Inc. (Nasdaq: NEO) shares declined 5.27% in Tuesday’s trading session following the release of its fourth quarter and full…

Krystal Biotech Surpasses Expectations as VYJUVEK Drives Record 2025 Revenue and International Expansion

Krystal Biotech, Inc. (NASDAQ: KRYS), a leader in redosable gene therapies, today announced record-breaking financial results for the fourth quarter…

Ceragon Full year 2025 Revenue Totals $338.7 million

Ceragon Networks Ltd. (Nasdaq: CRNT) shares declined 7.30% in Tuesday’s trading session following the release of its fourth-quarter and full-year…